{
    "eid": "2-s2.0-85041930503",
    "title": "High prevalence of hepatitis B-antibody loss and a case report of de novo hepatitis B virus infection in a child after living-donor liver transplantation",
    "cover-date": "2018-02-14",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Anti-HBs antibody",
        "De novo hepatitis B infection",
        "Hepatitis B vaccine",
        "Immunity",
        "Liver transplantation"
    ],
    "authors": [
        "Palittiya Sintusek",
        "Nawarat Posuwan",
        "Piyaporn Wanawongsawad",
        "Suttiruk Jitraruch",
        "Yong Poovorawan",
        "Voranush Chongsrisawat"
    ],
    "citedby-count": 9,
    "ref-count": 29,
    "ref-list": [
        "Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers",
        "Prospects for control of hepatitis B virus infection: Implications of childhood vaccination and long-term protection",
        "Persistence of antibodies to the surface antigen of the hepatitis B virus (anti-HBs) in children subjected to the Expanded Programme on Immunization (EPI), including hepatitis-B vaccine, in Thailand",
        "Transcriptional control of B cell development and function",
        "ELISPOT for detecting antibody-secreting cells in response to infections and vaccination",
        "Vaccineinduced immunity in children after orthotopic liver transplantation: A 12-yr review of the Swiss national reference center",
        "High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients",
        "High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection",
        "Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients",
        "Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation",
        "AST Infectious Diseases Community of Practice. Guidelines for vaccination of solid organ transplant candidates and recipients",
        "2013 IDSA clinical practice guideline for vaccination of the immunocompromised host",
        "Vaccination in solid organ transplantation",
        "Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants",
        "Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study",
        "Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen-positive liver donation: A survey of North American, European, and Asian-Pacific transplant programs",
        "Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: A systematic review",
        "Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease",
        "Reestablishment of active immunity against HBV graft reinfection after liver transplantation for HBV-related end stage liver disease",
        "Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: A 15-year follow-up study",
        "Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: A follow-up study at 15 years",
        "Are booster immunisations needed for lifelong hepatitis B immunity?",
        "Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation",
        "Response to booster hepatitis B vaccines in liver-transplanted children primarily vaccinated in infancy",
        "Vaccination against hepatitis B in liver transplant recipients: Pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells",
        "Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2",
        "Albumin gains immune boosting credibility",
        "Regulation of immune responses by prostaglandin E2"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "National Science and Technology Development Agency"
    ]
}